| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |